Marks Gilbert Lynn - Insider Non-Derivative Transactions at AN2 Therapeutics, Inc. (ANTX) - (SEC)
Updated on January 3, 2026.
According to recent SEC insider information filed on Oct 10, 2025, Marks Gilbert Lynn's relationship to AN2 Therapeutics, Inc. (ANTX) is Director, and currently has 63,749 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ANTX insiders.
Related Topics: SEC Topic List.
Data Source: SEC.
Marks Gilbert Lynn - Insider Non-Derivative Transactions of ANTX Common Stock
Marks Gilbert Lynn - Insider Non-Derivative Transactions at ANTX
Items per page:
25
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Oct 11, 2025 | Acquisition -- (Common Stock) | 10367 | 0 | 63749 |
| Jul 11, 2025 | Acquisition -- (Common Stock) | 11875 | 0 | 53382 |
| Apr 11, 2025 | Acquisition -- (Common Stock) | 9705 | 0 | 41507 |
| Dec 20, 2024 | Acquisition -- (Common Stock) | 8972 | 0 | 31802 |
Popular Topics:
Find us
Copyright © Beautify Data LLC. All Rights Reserved.